|
CN111560483A
|
|
Reaction system for detecting low-abundance novel coronavirus, method and application
|
|
CN111206080A
|
|
Method for detecting fragmented nucleic acid mutation and methylation based on nanopore sequencing
|
|
CN111394487A
|
|
Method for detecting mycobacterium tuberculosis and drug resistance thereof
|
|
CN111249454A
|
|
Use of inactivated BCG for preventing or treating a new coronavirus related condition
|
|
CN111081316A
|
|
Method and device for screening new coronary pneumonia candidate drugs
|
|
CN111020019A
|
|
Method for gene fusion detection based on nanopore technology
|
|
CN111368132A
|
|
Method for storing audio or video files based on DNA sequences and storage medium
|
|
CN110724765A
|
|
Gene containing HPV integration site and application thereof
|
|
CN110527714A
|
|
For detecting HPV in the method for the integration site of host genome
|
|
CN109355360A
|
|
For detecting composition, kit and the method for EGFR mutation
|
|
CN109055509A
|
|
Method, composition and purposes based on microsatellite instability of the two generation sequencing technologies detection without check sample
|
|
CN108389625A
|
|
Computer system for assessing relapse and metastasis risk after drug therapy
|
